Zimmer Biomet Holdings, Inc. (ZBH)
NYSE · Healthcare · Medical - Devices
Profile
Zimmer Biomet Holdings, Inc.
- Exchange
- NYSE
- Ticker
- ZBH
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Key facts
Zimmer Biomet Holdings, Inc.: key facts
- Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a Medical - Devices company in the Healthcare sector.
- In fiscal 2025, Zimmer Biomet Holdings, Inc. reported revenue of $8.2B and net income of $705.2M.
- Revenue grew 4.8% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $8.5B and net income was $806.8M.
MonkScore
Zimmer Biomet Holdings, Inc.'s MonkScore
MonkScore
MonkScore range: 20–30
as of October 2026
Sector rank: 496 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth10–20
- Profitability30–40
- Quality70–80
- Market Conviction10–20
- Safety20–30
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Zimmer Biomet Holdings, Inc.'s annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $8.5B | $8.2B | $7.7B | $7.4B | $6.9B | $6.8B |
| Gross profit | $5.9B | $5.1B | $5.5B | $5.3B | $4.9B | $4.9B |
| Operating income | $1.3B | $1.4B | $1.3B | $1.3B | $696.3M | $860.3M |
| Net income | $806.8M | $705.2M | $903.8M | $1.0B | $231.4M | $401.6M |
| Operating cash flow | $1.7B | $1.7B | $1.5B | $1.6B | $1.3B | $1.5B |
| Capital expenditure | $86.8M | -$224.5M | -$356.8M | -$394.5M | -$217.6M | -$152.0M |
| Free cash flow | $1.8B | $1.5B | $1.1B | $1.2B | $1.1B | $1.3B |
| Total debt | $7.5B | $7.5B | $6.2B | $5.8B | $5.7B | $7.1B |
| Cash | $410.0M | $591.9M | $525.5M | $415.8M | $375.7M | $378.1M |
Revenue growth a year
- 1-year
- 7.2%
- 3-year
- 5.9%
- 4-year
- 4.8%
Compound growth between fiscal years.
Peers
Similar companies
- Integer Holdings CorporationNYSE:ITGRMonkScore range: 20–30
- Artivion, Inc.NYSE:AORTMonkScore range: 30–40
- Abbott LaboratoriesNYSE:ABTMonkScore range: 30–40
- CONMED CorporationNYSE:CNMDMonkScore range: 30–40
- Medtronic plcNYSE:MDTMonkScore range: 30–40
- Sight Sciences, Inc.NASDAQ:SGHTMonkScore range: 30–40
- Orthofix Medical Inc.NASDAQ:OFIXMonkScore range: 40–50
- Establishment Labs Holdings Inc.NASDAQ:ESTAMonkScore range: 40–50
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.